U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07027254) titled 'PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism' on June 04.

Brief Summary: This study is a randomized controlled trial to assess the clinical utility of gallium-68 pentixafor PET/CT in the management of primary aldosteronism (PA). We aim to evaluate whether the addition of 68Ga-pentixafor PET/CT to standard adrenal venous sampling (AVS) improves surgical outcomes in patients with unilateral PA.

Study Start Date: June 25

Study Type: INTERVENTIONAL

Condition: Primary Aldosteronism Secondary Hypertension Aldosterone-Producing Adenoma Idiopathic Hyperaldosteronism Adrenalectomy

Int...